Pacific Bio (PACB) Misses Q3 EPS by 1c

Pacific Bio (NASDAQ: PACB) reported Q3 EPS of ($0.23), $0.01 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $34.9 million versus the consensus estimate of $33.23 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
• FS Bancorp (FSBW) Tops Q1 EPS by 8c
• Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance